Cigna Group

More Details of Cigna Group Company

The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical plan services and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, and clinical programs to help its clients.

Company Info

Company codeCI

Company nameCigna Group

IPO dateApr 01, 1982

Founded at2018

CEOMr. David M. Cordani, CPA

Number of employees73500

Security typeOrdinary Share

Fiscal year-endApr 01

Address- -

City- -

Stock exchangeNYSE Consolidated

Country- -

Postal code- -

Phone- -

Website- -

Company codeCI

IPO dateApr 01, 1982

Founded at2018

Company Executives

Name

Name/Position

Position

Shareholding

Change

Mr. David M. Cordani, CPA

Chairman of the Board, Chief Executive Officer

667.15K

-3.82%

Mr. Brian C. Evanko

President, Chief Operating Officer

64.33K

+18.95%

Ms. Donna F. Zarcone, CPA

Independent Director

26.10K

--

Mr. Eric C. Wiseman

Lead Independent Director

22.52K

--

Ms. Noelle K. Eder

Executive Vice President, Global Chief Information Officer

21.71K

-31.41%

Dr. David J. Brailer, M.D., Ph.D.

Executive Vice President, Chief Health Officer and Chief Transformation Officer

17.82K

+97.02%

Dr. Mark B. Mcclellan, M.D., Ph.D.

Independent Director

5.47K

--

Maj. Gen. (Retd.) Elder Granger, M.D.

Independent Director

5.47K

--

Ms. Kathleen M. Mazzarella

Independent Director

5.47K

--

Ms. Kimberly A. Ross

Independent Director

3.87K

--

Name

Name/Position

Position

Shareholding

Change

Mr. David M. Cordani, CPA

Chairman of the Board, Chief Executive Officer

667.15K

-3.82%

Mr. Brian C. Evanko

President, Chief Operating Officer

64.33K

+18.95%

Ms. Donna F. Zarcone, CPA

Independent Director

26.10K

--

Mr. Eric C. Wiseman

Lead Independent Director

22.52K

--

Ms. Noelle K. Eder

Executive Vice President, Global Chief Information Officer

21.71K

-31.41%

Dr. David J. Brailer, M.D., Ph.D.

Executive Vice President, Chief Health Officer and Chief Transformation Officer

17.82K

+97.02%

Revenue Breakdown

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2018

By BusinessUSD

Name

Revenue

Proportion

Pharmacy revenues

185.36B

0.00%

Network revenues

105.34B

0.00%

Home delivery and specialty revenues

72.48B

0.00%

Fees and other revenues

14.79B

0.00%

Other revenues

11.54B

0.00%

Intercompany eliminations

-4.06B

0.00%

No Data

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

Pharmacy revenues

185.36B

0.00%

Network revenues

105.34B

0.00%

Home delivery and specialty revenues

72.48B

0.00%

Fees and other revenues

14.79B

0.00%

Other revenues

11.54B

0.00%

Intercompany eliminations

-4.06B

0.00%

Shareholder

Update time: Fri, Feb 21

Shareholder Statistics

Type

Shareholder Statistics

Shareholder

Proportion

The Vanguard Group, Inc.

9.58%

BlackRock Institutional Trust Company, N.A.

4.94%

State Street Global Advisors (US)

4.69%

MFS Investment Management

4.14%

T. Rowe Price Associates, Inc.

3.90%

Other

72.75%

Shareholder Statistics

Shareholder

Proportion

The Vanguard Group, Inc.

9.58%

BlackRock Institutional Trust Company, N.A.

4.94%

State Street Global Advisors (US)

4.69%

MFS Investment Management

4.14%

T. Rowe Price Associates, Inc.

3.90%

Other

72.75%

Type

Shareholder

Proportion

Investment Advisor

41.68%

Investment Advisor/Hedge Fund

40.28%

Pension Fund

2.43%

Research Firm

2.30%

Hedge Fund

2.01%

Bank and Trust

1.67%

Sovereign Wealth Fund

1.27%

Corporation

1.17%

Individual Investor

0.40%

Other

6.80%

Institutional Shareholding

Update time: Sun, Jan 19

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q1

2896

255.63M

94.28%

-3.16M

2024Q4

2993

255.45M

93.32%

-4.13M

2024Q3

2931

253.73M

90.72%

-10.03M

2024Q2

2910

254.99M

91.23%

-15.89M

2024Q1

2865

261.02M

89.38%

-14.30M

2023Q4

2815

267.28M

91.36%

-8.83M

2023Q3

2725

267.63M

91.08%

-13.20M

2023Q2

2737

270.13M

91.28%

-8.82M

2023Q1

2710

268.83M

90.70%

-14.56M

2022Q4

2688

273.82M

91.52%

-15.33M

Shareholder Activity

Name

Shares Held

Proportion

Change

Chg %

Date

The Vanguard Group, Inc.

25.98M

9.58%

+22.81K

+0.09%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

13.39M

4.94%

+8.80K

+0.07%

Dec 31, 2024

State Street Global Advisors (US)

12.72M

4.69%

-105.73K

-0.82%

Dec 31, 2024

MFS Investment Management

11.23M

4.14%

+489.58K

+4.56%

Dec 31, 2024

T. Rowe Price Associates, Inc.

10.56M

3.9%

-1.12M

-9.58%

Dec 31, 2024

Fidelity Management & Research Company LLC

9.98M

3.68%

-1.68M

-14.38%

Dec 31, 2024

Dodge & Cox

8.77M

3.24%

-16.81K

-0.19%

Dec 31, 2024

Sanders Capital, LLC

8.05M

2.97%

+154.42K

+1.95%

Dec 31, 2024

Geode Capital Management, L.L.C.

5.96M

2.2%

+101.74K

+1.74%

Dec 31, 2024

GQG Partners, LLC

4.02M

1.48%

+737.10K

+22.44%

Dec 31, 2024

Related ETFs

Update time: Sun, Apr 6

Name

Proportion

iShares U.S. Healthcare Providers ETF

10.63%

VictoryShares Free Cash Flow ETF

4.13%

First Trust Large Cap US Equity Select ETF

3.93%

Monarch Dividend Plus Index ETF

3.5%

Davis Select US Equity ETF

2.89%

Simplify Health Care ETF

2.76%

Fidelity Blue Chip Value ETF

2.7%

Hennessy Stance ESG ETF

2.61%

VictoryShares US Multi-Factor Minimum Vol ETF

2.53%

Brandes US Value ETF

2.25%

iShares U.S. Healthcare Providers ETF

Proportion10.63%

VictoryShares Free Cash Flow ETF

Proportion4.13%

First Trust Large Cap US Equity Select ETF

Proportion3.93%

Monarch Dividend Plus Index ETF

Proportion3.5%

Davis Select US Equity ETF

Proportion2.89%

Simplify Health Care ETF

Proportion2.76%

Fidelity Blue Chip Value ETF

Proportion2.7%

Hennessy Stance ESG ETF

Proportion2.61%

VictoryShares US Multi-Factor Minimum Vol ETF

Proportion2.53%

Brandes US Value ETF

Proportion2.25%

Dividend

A total of 5.74B USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

Jan 30, 2025

CI.NB Interim Cash Dividend of gross USD 1.51 paid on Mar 20, 2025 going ex on Mar 05, 2025 with reinvestment option

Mar 05, 2025

Mar 20, 2025

Mar 05, 2025

Oct 23, 2024

CI.NB Final Cash Dividend of gross USD 1.4 paid on Dec 19, 2024 going ex on Dec 04, 2024

Dec 04, 2024

Dec 19, 2024

Dec 04, 2024

Jul 24, 2024

CI.NB Interim Cash Dividend of gross USD 1.4 paid on Sep 19, 2024 going ex on Sep 04, 2024 with reinvestment option

Sep 04, 2024

Sep 19, 2024

Sep 04, 2024

Apr 24, 2024

CI.NB Interim Cash Dividend of gross USD 1.4 paid on Jun 20, 2024 going ex on Jun 04, 2024 with reinvestment option

Jun 04, 2024

Jun 20, 2024

Jun 04, 2024

Feb 02, 2024

CI.NB Interim Cash Dividend of gross USD 1.4 paid on Mar 21, 2024 going ex on Mar 05, 2024 with reinvestment option

Mar 06, 2024

Mar 21, 2024

Mar 05, 2024

Oct 25, 2023

CI.NB Final Cash Dividend of gross USD 1.23 paid on Dec 21, 2023 going ex on Dec 05, 2023

Dec 06, 2023

Dec 21, 2023

Dec 05, 2023

Jul 26, 2023

CI.NB Interim Cash Dividend of gross USD 1.23 paid on Sep 21, 2023 going ex on Sep 05, 2023 with reinvestment option

Sep 06, 2023

Sep 21, 2023

Sep 05, 2023

Apr 26, 2023

CI.NB Interim Cash Dividend of gross USD 1.23 paid on Jun 22, 2023 going ex on Jun 06, 2023 with reinvestment option

Jun 07, 2023

Jun 22, 2023

Jun 06, 2023

Feb 03, 2023

CI.NB Interim Cash Dividend of gross USD 1.23 paid on Mar 23, 2023 going ex on Mar 07, 2023 with reinvestment option

Mar 08, 2023

Mar 23, 2023

Mar 07, 2023

Oct 26, 2022

CI.NB Final Cash Dividend of gross USD 1.12 paid on Dec 21, 2022 going ex on Dec 05, 2022

Dec 06, 2022

Dec 21, 2022

Dec 05, 2022

Stock Split

Date

Type

Ratio

No Data

Date

Type

Ratio

No Data

335.510USD

Cigna Group

335.510

Overview

Company